Makers of Ozempic, Mounjaro race to ramp up supply amid skyrocketing demand for drugs for weight loss

Novo Nordisk and Eli Lilly, makers of two of the most popular new weight loss drugs, can’t manufacture the meds fast enough to keep up with all the patients who want them. What are they doing to ramp up the supply?

Read more at CNN